Tuesday, June 08, 2004
Now, we see an indication that surgical treatment of sleep apnea can result in measurable improvements in anxiety and depression -- and the degree of psychiatric improvement is not strongly associated with the changes in objective tests.
In this study, the objective tests included measurements of the frequency of apneas (periods of interrupted breathing), and measurement of blood oxygen saturation (how much oxygen is present in the arterial blood.) Overall sleepiness was assessed using the Epworth Sleepiness Scale. (See link in sidebar.)
Laryngoscope. 114(6):1098-1102, June 2004.
Li, Hsueh-Yu MD; Huang, Yu-Shu MD; Chen, Ning-Hung MD; Fang, Tung-Jen MD; Liu, Chia-Yih MD; Wang, Pa-Chun MD, MSc
Objective: Patients with obstructive sleep apnea (OSA) may experience unfavorable psychologic symptoms such as depression and anxiety. The aim of this study was to confirm this hypothesis and to investigate whether the psychologic symptoms among OSA patients can be relieved by surgical intervention.
Study Design: Prospective, longitudinal intervention study.
The 5-Item Mental Health scale (MH-5) was used to evaluate the
postoperative changes of mood after extended uvulopalatal flap (EUPF)
surgery on 84 Taiwanese patients with OSA. The preoperative and
postoperative MH-5 data obtained from these patients were compared with
a Taiwanese population norm.
Results: Before surgery, the MH-5 scores of the OSA patients were significantly worse than the Taiwanese population norm of 72.8 (P < .0001). Postoperatively, mean MH-5 scores significantly increased from 61.8 +/- 16.0 to 70.0 +/- 15.8 (P = .0006). The effect size of this score change was 0.51, indicating a moderate degree of mood improvement. However, this score was still inferior to that of the population norm (P = .0045). The mood improvement was not significantly associated with the changes in either sleep apnea events or the level of sleepiness. Neither the changes in respiratory disturbance index (P = .4382), maximum arterial oxygen saturation (P = .4866), nor the change in Epworth Sleepiness Scale scores (P = .4951) were predictive of the MH-5 score improvement (R2 = 0.07).
Conclusions: This study demonstrated that patients with OSA had a higher level of anxiety, depression, and probable behavior or personality changes than the population norm. EUPF surgery could significantly improve the mood status among OSA patients; the effect of surgery was mild but clinically relevant. However, the extent of mood improvement experienced by OSA patients receiving operations may not simply be attributable to the changes in sleep apnea events or a reduced level of sleepiness.
The American Laryngological, Rhinological & Otological Society, Inc.
I am not familiar with the instrument they used to assess psychiatric symptoms: the MH-5. It is not widely used in psychiatry, so there is a chance that it is not really a valid measure of clinical syndromes. Taking it at face value, though, assuming the MH-5 actually means something, it would be of great interest to look at the individual patients, see which ones got the greatest mental health boost from the surgery, and try to figure out what is different about them, as compared to the patients who had the surgery but did not have improvements in mood and anxiety.
The reason this is important is that psychiatric disorders are defined by symptoms, not by underlying causes. This is a known problem in psychiatric research. Everyone in the field wants to come up with so way of subdividing the population of depressed patients into groups that would correlate with treatment responses. That way, we would not end up given treatments that are not likely to work, to patients who really need some other kind of treatment.
With the exception of atypical depression (which responds preferentially to MAOI's) and psychotic depression (which responds preferentially to a combination of an antidepressant and an antipsychotic), we have not had much success in subdividing the types of depression into clinically relevant groups. There is hope that functional neuroimaging -- fMRI and PET -- could be useful in this regard. So far, however, all we have is tantalizing clues; nothing really useful has come of it so far. If there is a relationship between sleep architecture and subtypes of depression, that would be good to know.
(Note: The Rest of the Story/Corpus Callosum has moved. Visit the new site here.)
E-mail a link that points to this post: